|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
ForSight Labs, Newly Formed Ophthalmic Device Incubator, Receives $2.4-million in Venture Funding
January 10th, 2006 No comments
ForSight Labs, which aims to create new companies around promising ophthalmic medical device technologies, announced last week its formation with seed funding of $2.4 million. The funding comes from three venture capital firms: Morgenthaler Ventures, Split Rock Partners and Versant Ventures.
The new incubator will be based on a collaboration between Eugene de Juan, M.D., and The Foundry. Dr. de Juan is Jean Kelly Stock Distinguished Professor of Ophthalmology at the University of California at San Francisco’s School of Medicine and has frequently been listed as one of the top 10 practicing ophthalmologists in the U.S. He has also cofounded five ophthalmic device companies and holds over 40 drug and device patents. The Foundry, founded in 1998 and based in Menlo Park, has founded nine new medical device companies, mostly focused on cardiovascular therapies. Together, these device companies have attained a current combined valuation of over $500 million.
ForSight Labs will combine Dr. de Juan’s ability as an ophthalmic therapy innovator with The Foundry’s proven process for device company creation. That process begins with evaluation of device ideas from around the world, selection every year of one idea with exceptional medical and commercial potential, device prototyping and testing that leads to proof of concept, and, finally, creation of a full-fledged company capable of attracting venture capital investment. The Foundry raises significant funding for the company and continues to assist it as it exits The Foundry’s offices and begins an independent existence.
“I looked at a number of successful device incubator models, but The Foundry’s model stood out,” says Dr. de Juan, who cites The Foundry’s unusually close alignment of interests between device developers and investors. “As an inventor, the Foundry model allows me to do my job unfettered.”
The three venture capital investors will each take a seat on the ForSight Labs board of directors.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility